- Latest available (Revised)
- Point in Time (20/01/2008)
- Original (As adopted by EU)
Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Version Superseded: 06/07/2009
Point in time view as at 20/01/2008.
There are currently no known outstanding effects for the Council Regulation (EEC) No 2377/90 (repealed), Division
4.
.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
[F2Carprofen | Carprofen | Bovine Not for use in animals from which milk is produced for human consumption | 500 μg/kg | Muscle | |
1 000 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
Equidae | 500 μg/kg | Muscle | |||
1 000 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ] | |||
Vedaprofen | Vedaprofen | Equidae | 50 μg/kg | Muscle | |
20 μg/kg | Fat | ||||
100 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
[F3Carprofen | Sum of carprofen and carprofen glucuronide conjugate | Bovine, equidae | 500 μg/kg | Muscle | |
1 000 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
1 000 μg/kg | Kidney] |
Textual Amendments
F2 Inserted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F3 Inserted by Commission Regulation (EC) No 869/2005 of 8 June 2005 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
[F4Flunixin | Flunixin | Bovine | 20 μg/kg | Muscle | |
30 μg/kg | Fat | ||||
300 μg/kg | Liver | ||||
100 μg/kg | Kidney | ||||
5-Hydroxyflunixin | 40 μg/kg | Milk | |||
Flunixin | Porcine | 50 μg/kg | Muscle | ||
10 μg/kg | Skin and fat | ||||
200 μg/kg | Liver | ||||
30 μg/kg | Kidney | ||||
[F5Equidae | 10 μg/kg | Muscle | |||
20 μg/kg | Fat | ||||
100 μg/kg | Liver | ||||
200 μg/kg | Kidney | ] ] | |||
Tolfenamic acid | Tolfenamic acid | Bovine | 50 μg/kg | Muscle | |
400 μg/kg | Liver | ||||
100 μg/kg | Kidney | ||||
50 μg/kg | Milk | ||||
Porcine | 50 μg/kg | Muscle | |||
400 μg/kg | Liver | ||||
100 μg/kg | Kidney |
Textual Amendments
F4 Inserted by Commission Regulation (EC) No 2728/1999 of 20 December 1999 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
F5 Inserted by Commission Regulation (EC) No 2908/2000 of 29 December 2000 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Meloxicam | Meloxicam | Equidae | 20 μg/kg | Muscle | |
65 μg/kg | Liver | ||||
65 μg/kg | Kidney | ] |
Textual Amendments
F6 Inserted by Commission Regulation (EC) No 1530/2002 of 27 August 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
[F8Meloxicam | Meloxicam | Porcine, equidae, rabbit | 20 μg/kg | Muscle | |
65 μg/kg | Liver | ||||
65 μg/kg | Kidney | ||||
Bovine, caprine | 20 μg/kg | Muscle | |||
65 μg/kg | Liver | ||||
65 μg/kg | Kidney | ||||
15 μg/kg | Milk] ] |
Textual Amendments
F8 Substituted by Commission Regulation (EC) No 1805/2006 of 7 December 2006 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards thiamphenicol, fenvalerate and meloxicam (Text with EEA relevance).
Textual Amendments
F7 Inserted by Commission Regulation (EC) No 2393/1999 of 11 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Metamizole | 4-Methylaminoantipyrin | Bovine | 100 μg/kg | Muscle | |
100 μg/kg | Fat | ||||
100 μg/kg | Liver | ||||
100 μg/kg | Kidney | ||||
50 μg/kg | Milk | ||||
Porcine | 100 μg/kg | Muscle | |||
100 μg/kg | Skin and fat | ||||
100 μg/kg | Liver | ||||
100 μg/kg | Kidney | ||||
Equidae | 100 μg/kg | Muscle | |||
100 μg/kg | Fat | ||||
100 μg/kg | Liver | ||||
100 μg/kg | Kidney | ] |
Textual Amendments
F9 Inserted by Commission Regulation (EC) No 2011/2003 of 14 November 2003 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
a Not for use in animals from which milk is produced for human consumption.] | |||||
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Diclofenac | Diclofenac | Bovine a | 5 μg/kg | Muscle | |
1 μg/kg | Fat | ||||
5 μg/kg | Liver | ||||
10 μg/kg | Kidney | ||||
Porcine | 5 μg/kg | Muscle | |||
1 μg/kg | Skin + fat | ||||
5 μg/kg | Liver | ||||
10 μg/kg | Kidney |
Textual Amendments
F10 Inserted by Commission Regulation (EC) No 324/2004 of 25 February 2004 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
---|---|---|---|---|---|
Firocoxib | Firocoxib | Equidae | 10 μg/kg | Muscle | |
15 μg/kg | Fat | ||||
60 μg/kg | Liver | ||||
10 μg/kg | Kidney] ] |
Textual Amendments
F11 Inserted by Commission Regulation (EC) No 1323/2007 of 12 November 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards firocoxib (Text with EEA relevance).
Textual Amendments
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: